Rocket One RKTO
NASDAQ RKTO
$0.55 +0.02 (+3.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rocket One (RKTO) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

Rocket One (RKTO) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Rocket One 12.75 Mn -13.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 147,202.00
Dec 31, 2022 1.00
Sep 30, 2022 -2.00
Sep 30, 2021 514,910.00
Jun 30, 2021 966,085.00
Mar 31, 2021 1.03 Mn
Dec 31, 2020 38,213.00
Sep 30, 2020 751,606.00
Mar 31, 2020 300,000.00
API Access

Rocket One Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RKTO&period=max&api_key=YOUR_API_KEY